⌘K

Home/Filings/4/0001209191-23-054018

4//SEC Filing

Crockett Thomas Andrew 4

Accession 0001209191-23-054018

CIK 0001348911other

View on SEC.gov Company Profile

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 4:12 PM ET

Size

4.9 KB

Accession

0001209191-23-054018

Insider Transaction Report

Form 4

Period: 2023-10-30

KalVista Pharmaceuticals, Inc.KALV

Crockett Thomas Andrew

DirectorPresident and CEO

Transactions

Gift
Common Stock
2023-10-30−8,000→ 138,756 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

KalVista Pharmaceuticals, Inc.

CIK 0001348911

Entity typeother

Related Parties

1

filerCIK 0001690920

Filing Metadata

Form type: 4
Filed: Oct 31, 8:00 PM ET
Accepted: Nov 1, 4:12 PM ET
Size: 4.9 KB

View on SEC.gov